Mylan Recalls Capecitabine Tablets Due to Dissolution Failures
Mylan Pharmaceuticals is recalling 1,068 bottles of Capecitabine Tablets, 500 mg, because the product failed to meet dissolution specifications.
- Product
- Capecitabine Tablets, USP, 500 mg, 120-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-2512-78, UPC 3 0378-2512-78 6.
- Category
- Drug
- Distribution
- Distributed nationwide